$AEHR

POSEDEL RHEA J sold $836K of AEHR (indirect holdings)

POSEDEL RHEA J (Director) sold 5,973 indirectly-held shares of AEHR TEST SYSTEMS (AEHR) at $140.00 ($0.84M total) on 2026-08-14.

Original reporting
SEC EDGAR · POSEDEL RHEA J
Published Aug 14, 2026, 9:46 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The disclosed sale provides incremental sentiment information but no new information about AEHR’s business performance, guidance, or risk factors.

02

Market read

Traders may monitor for follow-on insider activity, but this single Form 4 sale is not a standalone catalyst.

03

What to watch

The filing notes the sale was indirect and does not state a 10b5-1 plan; traders may over-interpret intent without knowing tax, diversification, or pre-existing arrangements.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-08-14, reflecting an insider sale executed the same day.

Background

The article is a SEC Form 4 insider transaction disclosure for AEHR, listing the director’s role and the details of an open-market sale.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Director POSEDEL RHEA J sold 5,973 shares of AEHR on 2026-08-14 for about $836,220, reported as an indirect open-market sale.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing discloses the transaction size, price ($140/share), and that it was an open-market sale with no 10b5-1 plan stated. However, insider sales are common and the article provides no new operational, financial, or regulatory catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management and does not necessarily signal reduced confidence, especially without any accompanying negative company news.

Key entities

  • AEHR

    AEHR Test Systems, the issuer of the Form 4 insider transaction.

  • POSEDEL RHEA J

    Director of AEHR who sold shares via an indirect open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 8/10

AEHR Stock Rips On AI Orders And Bullish Jefferies Call

Aehr Test Systems (NASDAQ: AEHR) rose about 7% after upbeat earnings and strong semiconductor test demand. The article cites a $22M AI follow-on production order and a Jefferies Buy call with a $175 price target. It also notes quarterly revenue of about $18.84M, gross margin 35.3%, and $116.36M cash.

$AEHRMed

Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

Jefferies initiated coverage of Aehr Test Systems (AEHR) with a Buy rating and $175 price target, citing a conservative model based on existing production and backlog. The stock rose about 8% midday and is up over 510% YTD, after AI-driven semiconductor testing demand. Peers TER, COHU, FORM, and ONTO also gained; AEHR faces valuation and revenue volatility risks.

$AEHRHighAI 9/10

Why is Aehr Test Systems stock surging today?

Investing.com reports Aehr Test Systems (AEHR) shares rose 10.7% after the company said it received a $22 million follow-on production order from a lead wafer-level AI processor customer. The order covers FOX-XP burn-in systems, FOX WaferPak contactors, and Auto Aligners. AEHR also reported fiscal Q4 2026 profit of $0.11 EPS on ~$18.8M revenue and guided fiscal 2027 revenue to $130–$150M.

$AEHRMedAI 8/10

A $22 Million Reason Why AEHR Stock Is Up Today

Aehr Test Systems (AEHR) shares rose Aug. 12 after the company said it received a $22 million follow-on production order from its lead AI processor customer for automated wafer-level test systems. The order covers FOX-XP WLBI systems and related components, shipping over six months for installation in Taiwan. Investors cited demand tied to AI chip manufacturing; AEHR trades around 212x forward earnings and has a mean $115 price target.